NRx Pharmaceuticals, Inc. (NASDAQ:NRXPW) Short Interest Up 58.3% in February

NRx Pharmaceuticals, Inc. (NASDAQ:NRXPW) saw a large increase in short interest during the month of February. As of February 28th, there was short interest totalling 1,900 shares, an increase of 58.3% from the February 13th total of 1,200 shares. Based on an average daily volume of 24,900 shares, the days-to-cover ratio is currently 0.1 days.

NRx Pharmaceuticals Stock Down 33.4 %

NRXPW stock traded down $0.04 during mid-day trading on Monday, reaching $0.08. 19,677 shares of the stock traded hands, compared to its average volume of 35,105. NRx Pharmaceuticals has a 52 week low of $0.04 and a 52 week high of $0.50. The business has a 50-day moving average of $0.18 and a two-hundred day moving average of $0.11.

About NRx Pharmaceuticals

NRx Pharmaceuticals, Inc, a clinical-stage biopharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders, including suicidal depression, post-traumatic stress disorder, and chronic pain. Its products include NRX-101 (D-cycloserine/Lurasidone), an oral, fixed dosed combination of D-cycloserine and lurasidone that earned FDA-designated breakthrough therapy for suicidal treatment-resistant bipolar depression; and NRX-100 (ketamine), which has been awarded FDA fast track designation for the treatment of severe bipolar depression with acute suicidal ideation and behavior.